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Abstract
Background: Cerebral blood flow (CBF) is auto-regulated to meet the brain’s metabolic requirements. OxycyteH is a
perfluorocarbon emulsion that acts as a highly effective oxygen carrier compared to blood. The aim of this study is to
determine the effects of OxycyteH on regional CBF (rCBF), by evaluating the effects of stepwise isovolemic hemodilution
with OxycyteH on CBF.
Methodology: Male rats were intubated and ventilated with 100% O2 under isoflurane anesthesia. The regional (striatum)
CBF (rCBF) was measured with a laser doppler flowmeter (LDF). Stepwise isovolemic hemodilution was performed by
withdrawing 4ml of blood and substituting the same volume of 5% albumin or 2 ml OxycyteH plus 2 ml albumin at 20-
minute intervals until the hematocrit (Hct) values reached 5%.
Principal Findings: In the albumin-treated group, rCBF progressively increased to approximately twice its baseline level
(208630%) when Hct levels were less than 10%. In the OxycyteH-treated group on the other hand, rCBF increased by
significantly smaller increments, and this group’s mean rCBF was only slightly higher than baseline (118618%) when Hct
levels were less than 10%. Similarly, in the albumin-treated group, rCBF started to increase when hemodilution with albumin
caused the CaO2 to decrease below 17.5 ml/dl. Thereafter, the increase in rCBF was accompanied by a nearly proportional
decrease in the CaO2 level. In the OxycyteH-treated group, the increase in rCBF was significantly smaller than in the albumin-
treated group when the CaO2 level dropped below 10 ml/dl (142620% vs. 186626%), and rCBF returned to almost baseline
levels (106615) when the CaO2 level was below 7 ml/dl.
Conclusions/Significance: Hemodilution with OxycyteH was accompanied with higher CaO2 and PO2 than control group
treated with albumin alone. This effect may be partially responsible for maintaining relatively constant CBF and not allowing
the elevated blood flow that was observed with albumin.
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Introduction
Perfluorocarbon solutions (PFCs) are biochemically inert
organic compounds with a high affinity for oxygen and CO2 that
can improve tissue oxygenation when used with high inspiratory
concentrations of oxygen [1]. PFCs have long been proposed as
potential blood substitutes to reduce the need for allogeneic blood
transfusions in a variety of clinical situations. Although PFCs were
introduced in the 1970s, their applications and safety profiles have
yet to be defined [1,2].
The impact of PFCs on cerebral function is still under
investigation, including its effects on cerebral blood flow (CBF).
It is well known that hemodilution, characterized by decreased
hematocrit (Hct), lowered circulating oxygen content (CaO2), and
decreased blood viscosity can increase CBF [3–7]. Results of
animal studies suggest that PFC administration decreases cere-
brovascular resistance and blood viscosity, thereby increasing CBF
[8,9]. In most cases, increased CBF reflects increased metabolic
demand or decreased arterial oxygen content (CaO2), and may
indicate a need to increase cerebral oxygen delivery.
Because of the tiny particle size, PFC emulsions readily perfuse
in the microcirculation, resulting in augmented oxygen delivery to
the tissues more effectively than oxygen-carrying blood cells in the
large vessels [9]. Because of this simple physical transport system,
PFC emulsions load and unload oxygen twice as fast as does
hemoglobin [10]. Although the exact capacity of oxygen delivery
by PFC compared to Hb is not known, several reports indicate
that oxygen delivery potential of a 2.7 g/kg dose of PFC is
approximately equivalent to 4 g/dL [Hb] [11,12]. Although the
clinical importance of PFC-induced increases in CBF is unclear,
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patients with traumatic and ischemic brain injury [13–16].
OxycyteH is a perfluorocarbon emulsion that has the ability to
dissolve large amounts of oxygen, and has been shown to be a safe
blood alternative in Phase I clinical trials. OxycyteH particles can
be efficiently carried to tissues perfused at critically low flow rates,
while eliciting no vasoconstriction or associated pharmacological
disadvantage that prevents tissues from utilizing this oxygen. In a
model of permanent middle cerebral artery occlusion in rats
OxycyteH has been shown to decrease ischemic brain damage
[17]. A recent study showed that early administration of OxycyteH
immediately after the onset of vascular occlusion exerted a
neuroprotective effect in these rats [18].
Several studies showed that PFC emulsions have higher oxygen
carrying capacity compared to Hb, and are able to deliver twice the
oxygen to the tissues when combined with hyperoxic ventilation
[12,9–11]. Furthermore, Adminsitration of PFC emulsions has been
well tolerated by infused animals and has no negative effects on
microvascular perfusion [12,19]. To determine whether oxygen
utilization by cerebral tissue is modified when OxycyteH is used for
hemodilution, the present study was performed to evaluate the
effects of stepwise isovolemic hemodilution with OxycyteH on
regional CBF (rCBF) in experimental rats.
Methods
Experimental Animals
The proposed study was approved by the Institutional
Committee for the Humane Use of Animals at Upstate Medical
University, Syracuse, New York 13210, in accordance with the
guidelines established by the National Institutes of Health. The
work was performed in the Department of Anesthesiology Basic
Science Laboratory at SUNY Upstate Medical University.
Pathogen-free male Sprague-Dawley rats weighing between 350
to 400 g (Taconic Farm, Germantown, NY) were used. Rats were
kept in holding wire mesh cages for a week to acclimate them to
the study and environmental conditions. Standard rat chow (Diet
#5008, Ralston Purina, St. Louis, MO) and tap water were
provided ad libitum.
Surgical Procedures
All rats were anesthetized by intramuscular injection of a rodent
anesthetic mixture containing ketamine and xylazine (100:10 mg/
ml) at a dose of 1.0 ml/ kg. The neck, head and both groin regions
were shaved and the skin was prepared with 10% solution of
Povidone-Iodine (Betadine, Purdue Products L.P, Stamford, CT).
Body temperature was monitored with a rectal probe (Mon-a-
therm 6500, Mallinckrodt Medical, St. Louis, MO) and main-
tained at approximately 37.060.5uC with a heating pad and light.
Tracheostomy was performed and the rats were mechanically
ventilated (Harvard Apparatus, South Natick, MA) with 100%
oxygen at a frequency of 40 to 60/min and a tidal volume of
3.0 ml. End tidal CO2 pressure was kept close to 40 mmHg by
varying ventilation settings. Anesthesia was maintained with
isoflurane (Minrad inc., Bethlehem, PA) at an inspiratory
concentration of 1.2%. Both femoral arteries and veins were
cannulated with polyethylene tubing (ID 0.58mm, Becton-
Dickinson Co., Parsippany, NJ). Under anesthesia, the rats’ hair
was shaved on the ventral neck from the right groin to the mid-
thigh, and the area swabbed with iodine solution. A 1.5 cm
incision was made in the midline of the inner surface of the leg to
expose the femoral artery and vein. The right femoral artery and
vein were carefully separated with a pair of hemostats and a 5 cm
silk tie was tied loosely around the vessels. A small incision was
made and the catheter was inserted and secured with silk tie. The
skin was then closed. The left femoral artery and vein were
cannulated in the same manner. The right artery catheter was
used to monitor blood pressure, and the left artery catheter to
collect samples. The left venous catheter was used to infuse
phenylephrine and the right venous catheter was used to replace
collected blood volume according to the experimental protocol.
Regional Cerebral Blood Flow Measurement
After skin closure, the rat was placed prone on a stereotactic
frame (David Kopf Instruments, Tujunga, CA). A midline skin
incision over the skull was performed, and a small burr hole was
drilled. A 26 G, single-fibre laser-Doppler flow (LDF) probe (DP4,
Moor Instruments Inc, Wilmington, DE), connected to a monitor
(Moorlab server, Moor Instruments Inc., Wilmington, DE) was
inserted into the right striatum. The stereotactic coordinates from
the bregma were: medial lateral, 4 mm from the middle line and
dorsal–ventral, 4 mm ventral from the surface of the dura [20].
The LDF device was calibrated with a standard calibration
solution provided by the manufacturer. The probe was allowed to
stabilize for 20 minutes before a baseline signal was obtained,
which represented baseline (ie, 100%) rCBF. Changes in rCBF
were expressed as the percentage change from baseline.
Stepwise Isovolemic Hemodilution
All rats received 0.15 ml intravenous heparin (500 IU ml
21)t o
prevent bloodfrom coagulating inthe catheters.The baseline cmean
arterial pressure (MAP), arterial blood gases (ABG), Hct and rCBF
were obtained. The rats were randomized to OxycyteH-treated
(n=7) and albumin-treated (n=7) groups. Isovolemic hemodilution
was performed by removing 4 ml of blood at a rate of 0.5–1 ml/min
and then substituting the same amount of 5% albumin solution
(Baxter Healthcare Co., Glendale, CA) in albumin-treated control
rats or 2 ml OxycyteH (Synthetic Blood International Inc, Costa
Mesa, CA) plus 2 ml 5% albumin in OxycyteH-treated rats.
OxycyteH consists of a perfluoronated C-10, cyclohexane compound
[60%(wt/vol)]emulsion,witheggyolklecithinastheemulsifier.The
nominal diameter of emulsion particles was 0.2 mm. The oxygen
dissolving capacity of OxycyteH is (43) vol% (43 ml O2/100 ml pure
PFC) at 37uCa n d7 6 0m m H g O 2.
After the first hemodilution step, Hct was determined again,
and ABG was analyzed. The next steps of hemodilution were
calculated to serially approach target Hct of 25%, 20%, 15% and
12%. Hemodilution was continued stepwise at 20-minute
intervals. In the OxycyteH-treated group, the target concentration
of OxycyteH was between 7% and 10%. MAP was maintained
above 60 mmHg by continuous infusion of phenylephrine (Gensia
Sicor Inc. Irvine, CA) up to15 mcg/h. The experiment was
completed when Hct values reached 5%. The oxygen content
(CaO2) was calculated with the following equation:
CaO2~f1:36|½Hb |SaO2gzf0:003|PaO2gz
f(PFC O2 solubility)|PaO2|fluorocritg
Hb: hemoglobin; CaO2 : arterial oxygen content; SaO2 :
arterial saturation of Hb with oxygen (%); PaO2: arterial oxygen
partial pressure; fluocrit: arterial Oxycyte concentration.
Hb concentration was calculated from the Hct as follows: Hb
(g/dl)=Hct60.34 (Mean cell Hb concentrations were assumed to
be comparable in all rats). After hemodilution, supplemental
phenylephrine infusion was required in order to maintain blood
pressure within 10% of control especially after 2–3 hemodilution
steps.
OxycyteH, Cerebral Blood Flow
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All data were presented as Mean6SD. Changes within each
group were analyzed using the analysis of variance (ANOVA) for
repeated measures. Differences between the groups at any time
point were tested using two way ANOVA followed by the
Bonferroni test as a post–hoc test. P,0.05 is considered as a
statistically significant.
Results
OxycyteH hemodilution and circulating oxygen content
as determined by hemodynamic parameter
The rat groups treated with OxycyteH showed no significant
difference in MAP, PaCO2, or pH when compared to rat group
treated with albumin alone at the end of the experiment (Hct less
than 10%, Table 1). However, the PaO2 was significantly higher in
rats hemodiluted with OxycyteH than in rats hemodiluted with
albumin. Interestingly, a higher infusion rate of phenylephrine was
required to maintain MAP in the albumin group, but within a
reasonably low infusion rate. Furthermore, no significant change
in body temperature was observed between the two groups even
after a prolonged experiment over a duration of 5 hours (data not
shown).
OxycyteH and calculated arterial oxygen content
As shown in Figure 1, CaO2 progressively decreased, as did Hct
values, during stepwise isovolemic hemodilution in both albumin
and OxycyteH treated groups. Nevertheless, hemodilution with
OxycyteH produced significantly higher CaO2 levels than did
hemodilution with albumin; for the OxycyteH and albumin groups
(respectively): mean CaO2 levels were 15.660.5vs. 12.960.5
(p,0.05) at Hct level of 20–30%, 11.260.3 vs. 8.160.3 (p,0.05)
at Hct level of 10–20% and 7.560.3 vs. 4.560.2 (p,0.01) at Hct
level of less that 10%.
Hemodilution and regional cerebral blood flow
Hemodilution caused by both OxycyteH and albumin signifi-
cantly affected the relationship between rCBF and both Hct
(Figure 2) and CaO2 (Figure 3). In the albumin-treated group,
rCBF progressively increased to approximately twice its baseline
level when Hct levels were less than 10%. In the OxycyteH-treated
group on the other hand, rCBF increased by significantly smaller
increments, and this group’s mean rCBF was only slightly higher
than baseline when Hct levels decreased to less than 10%.
Similarly, in the albumin-treated group, rCBF started to increase
when hemodilution with albumin caused the CaO2 to decrease
below 17.5 ml/dl. Thereafter, the increase in rCBF was
accompanied by a nearly proportional decrease in the CaO2
level. In the Oxycyte-treated group, the increase in rCBF was
significantly smaller than in the albumin-treated group when the
CaO2 level dropped below 10 ml/dl, and rCBF returned to
almost baseline when the CaO2 level was below 7 ml/dl.
Discussion
In this study we show that acute isovolemic hemodilution with
OxycyteH maintains significantly higher circulating oxygen
content than does isovolemic dilution with albumin alone.
Furthermore, administration of both OxycyteH and albumin
Table 1. Hemodynamics and blood gas data at the point of
maximum hemodilution (n=7 in each group)
OxycyteH Albumin p
PaCO2 (mmHg) 37.1960.50 38.0160.74 0.351
PaO2 (mmHg) 502.1610.46 419.93615.92 ,0.001
pH 7.36960.006 7.37660.006 0.418
MAP (mmHg) 74.3260.87 73.5560.89 0.538
Phenylephrine (mcg/h) 1.9860.20 3.0660.34 0.002
weight (g) 3496 13 348611 0.928
Data as mean6SD (standard deviation of the mean)
doi:10.1371/journal.pone.0002010.t001
Figure 1. The changes of calculated arterial oxygen content
during acute isovolemic hemodilution with OxycyteH or
albumin. Hemodilution causes a progressive decrease in Hct level.
The arterial oxygen content decreases in an inverse proportion to the
levels of Hct during hemodilution with either albumin or OxycyteH.
However, the arterial oxygen content is maintained at a significantly
higher level during hemodilution with the OxycyteH group than in
hemodilution with the albumin group. Open bar: acute isovolemic
hemodilution with albumin; Shaded bar: acute isovolemic hemodilution
with OxycyteH.
doi:10.1371/journal.pone.0002010.g001
Figure 2. The changes of regional cerebral blood flow during
acute isovolemic hemodilution with OxycyteH or albumin.
Hemodilution causes a progressive decrease in Hct level. The regional
cerebral blood flow increases in an inverse proportion to the levels of
Hct and doubles from baseline when Hct level is lower than 10% during
hemodilution with albumin. During hemodilution with OxycyteH, the
regional cerebral blood flow increases to 150% of baseline when the
Hct is between 10–20% and then decreases to about 120% of baseline
when the Hct decreased to below 10%. Open bar: acute isovolemic
hemodilution with albumin; Shaded bar: acute isovolemic hemodilution
with OxycyteH.
doi:10.1371/journal.pone.0002010.g002
OxycyteH, Cerebral Blood Flow
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different patterns. With albumin, rCBF increased progressively in
inverse proportion to the decreased Hct and CaO2. Under the
most extreme isovolemic hemodilution conditions, rCBF was
approximately 170% higher in the albumin-treated group than in
the OxycyteH-treated group when the two groups were compared
at the same concentrations of Hct and circulating oxygen content
(i.e., Hct ,10% and CaO2 ,7.5 ml/dl), indicating that OxycyteH
has maintained baseline CBF. Table 1. shows that pH and PCO2
were kept constant in both groups.
Laser Doppler flowmeter (LDF) was used in the present study to
show the increase in rCBF after acute hemodilution with
OxycyteH or albumin. As Tonnesen et al [21] have pointed out,
LDF is a valuable tool for continuously measuring relative changes
in rCBF; for example, under conditions of hypovolemic hemodi-
lution and hemorrhagic shock caused by controlled hemorrhage,
the LDF method may yield significantly higher relative rCBF
values than the
133xenon injection technique. The advantage of
using LDF in cerebral perfusion studies is that this technique can
measure rCBF in vivo, continuously, for up to several hours.
Harada et al have reported the reproducibility of the LDF
monitoring in minimizing the risk and reducing intraanimal
variability and unexpected death for rat MCAO model [22].
The increase in CBF caused by hemodilution with PFC
emulsion has long been recognized; the mechanisms by which
PFC emulsions increase CBF are probably multifactorial. Lower
blood viscosity resulting from isovolemic hemodilution, the small
particle size of the PFC emulsion and decreased circulating oxygen
content are all contributing factors. Hiraga et al [23] used [14C]
iodoantipyrine and quantitative autoradiographic techniques to
measure local CBF in rats breathing 100% oxygen after blood-
PFC exchange. The CBF increased approximately two-fold after
complete blood-PFC exchange and 1.5-fold after partial exchange.
The authors attributed the increase in CBF to an autoregulatory
response of the central nervous system vasculature to maintain an
adequate supply of oxygen to the central the nervous system tissue.
Lee et al [24,25] used a radiolabeled-microsphere technique to
evaluate cerebrocirculatory responses to total perfluorocarbon
(FC-43) for-blood replacement (Hct less than 1%) in anesthetized,
ventilated rats breathing 100% O2. Exchange transfusion with FC-
43 doubled the total and regional CBF, causing preferential flow
increases to the cortex and cerebellum. Estimated cerebrovascular
resistance fell to 50% of the pre-exchange value. Both hemodi-
lution and hypoxia experiments produced CBF responses similar
to those obtained in FC-43 animals. Their results suggested that
decreased oxygen content and, perhaps, lower viscosity of the
circulating fluorocarbon were responsible for increases in CBF
required to maintain sufficient delivery of oxygen to the brain.
In the present study, partial OxycyteH-for-blood exchange
increased rCBF approximately 150%. However, rCBF did not
further increase in response to decreased Hct and circulating
oxygen content, but instead returned toward almost the baseline
level, while Hct decreased to less than 10% and CaO2 decreased
to less than 7.5 ml/dl. Increased rCBF in response to decreased
circulating oxygen content is a normal physiological response of
the brain. The reason for different of rCBF changes under extreme
conditions between our study and others [23–25] is unclear;
however, the different cerebral regions of measured blood flow
(striatum in our study) and the different structures of PFC
emulsions (OxycyteH in our study) may be partially responsible for
this discrepancy. The impact of perfluorocarbon emulsion on
neural cells’ structure and function warrants further investigations.
The present study’s findings suggest that when OxycyteH is used
for hemodilution, care should be taken to keep circulating oxygen
content from becoming too low (,7.5 ml/dl) to maintain
adequate oxygen tissue perfusion.
Under normal physiological conditions, increased CBF is
associated with improved cerebral oxygenation. Findings from
animal studies have suggested that the increased CBF and
improved oxygenation may be beneficial for patients with ischemic
and traumatic brain injury [13–16].
In the present study, the rats were anesthetized, and their
physiological parameters were kept within normal ranges (e.g.,
normal range of PaCO2/pH). The increased rCBF after isovolemic
hemodilution could be attributed to a cerebral autoregulatory
response that services to maintain a sufficient supply of oxygen and
normal cerebral functions. The reason for the smaller increase in
rCBF after hemodilution with OxycyteH than with albumin, even
when the circulating oxygen content was the same, is unknown.
Although calculated circulating oxygen content is the same, the
oxygenavailabilityofredbloodcells(RBCs)andPFCemulsionsmay
be different. The average particle diameter of PFC emulsions is
about 0.2 micron, compared to 5–7 microns for RBCs. An emulsion
of PFC, therefore, can further enhance tissue oxygenation by filling
the plasma gaps between RBCs and blood vessel walls and by
perfusing constricted microcapillaries too small for RBCs to pass,
thereby improving local tissue oxygenation [26]. The smaller
increase in rCBF after hemodilution with OxycyteH may therefore
account for the greater amount of available circulating oxygen in the
OxycyteH recipients.
As a recent study examined the rheologic effects of PFC
emulsion in the presence of clinically used volume expanders. The
authors observed that hemodilution with a new perfluorocarbon
emulsion significantly increased plasma and whole-blood viscosity.
Viscosity values were maintained at physiologic range when
human albumin-PFC mixture was used. Red blood cells deform-
ability was also observed unchanged [27]. It has also observed that
hemodynamic stability was better maintained when colloid
solutions, including albumin were used in hemodilution [19]. In
the present study, albumin was added to Oxycyte to minimize
possible increased blood viscosity caused by Oxycyte.
Figure 3. The changes of regional cerebral blood flow during
acute isovolemic hemodilution with OxycyteH or albumin.
Hemodilution causes a progressive decrease in arterial oxygen content
level. The regional cerebral blood flow continues to increase in an
inverse proportion to the levels of arterial oxygen content during
hemodilution with albumin. During hemodilution with OxycyteH, the
regional cerebral blood flow increases significantly less when arterial
oxygen content decreased to below 10 dl/ml. Open bar: acute
isovolemic hemodilution with albumin; Shaded bar: acute isovolemic
hemodilution with OxycyteH.
doi:10.1371/journal.pone.0002010.g003
OxycyteH, Cerebral Blood Flow
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used in lower hematocrit status (hemodilution, hemorrhage),
therefore so far there is no study to look into the effect of PFCs on
CBF under normal hematocrit status. In our study, stepwise
hemodilution was performed, there was no significant effect of
Oxycyte on rCBF when Hct was only minimally (Hct 30–40)
reduced, suggesting Oxycyte per se (in small doses) may have no
significant effect on CBF when given to normal Hct status. Few
studies in which second generation PFCs were added to the pump
prime have demonstrated improved tissue oxygenation and
increased cerebral blood flow [28–31].
One of the limitations in the present study was that moderate
phenylephrine infusion was necessary to maintain the hemody-
namic stability during acute hemodilution. Phenylephrine, a pure
alpha-adrenergic agonist, produces both venous and arterial
constriction. Excessive vasoconstriction and increased systemic
vascular resistance may decrease cardiac output, but the direct or
indirect effects of phenylephrine infusion on rCBF are unknown.
In the present study, rCBF was measured in the striatum only;
therefore, our data do not reflect blood flow changes that might
have occurred in other regions of the brain.
We therefore conclude that although OxycyteH and albumin
administration both were accompanied by an increase of rCBF
following acute isovolemic hemodilution, each does so with
different variability. The different patterns of increased rCBF
could be due to the ability of OxycyteH, as a true oxygen
therapeutic, to maintain higher levels of circulating oxygen content
under similar physiological conditions.
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